IndraLab

Statements


11 1 | 23 14

reach
"NEMO, another potential adaptor of CYLD, directly binds CYLD and associates with various IKK regulators, such as RIP1 and TRAF2 [XREF_BIBR]."

sparser
"Interestingly, the association of CYLD with IKKγ coincides with the appearance of a phosphorylated form of CYLD, though it has not been shown that this modification is required for interaction and deubiquitinating activities xref ."

No evidence text available

reach
"Three independent studies have recently shown that CYLD binds to NEMO and facilitates the disassembly of K63 linked polyubiquitin chains on TRAF2, TRAF6 and NEMO [22 ** -24 **]."

reach
"However, the SUMOylation effectively impairs the interaction between NEMO and CYLD, suggesting that the SUMO-moiety (~ 12 kDa) might directly mask the binding surface."

sparser
"Strikingly, GST-CYLD (470–684 aa) could pull down neither the NEMO-SUMO-3 nor the SUMOylated NEMO ( xref , left panel and xref ), whereas GST-IKKβ (644–756 aa) could pull down both the NEMO-SUMO-3 and the SUMOylated NEMO ( xref , right panel and xref ), indicating that the SUMO-3 modification specifically impaired the interaction between NEMO and CYLD."

reach
"Removal of Lys-63-chains from TRAFs requires that CYLD physically (and transiently) interact with NEMO, e.g. in response to TNF-alpha stimulation."

No evidence text available

reach
"For example, CYLD directly associates and deubiquitinates NEMO and TRAF-6, thus inhibiting TNF-alpha-induced nuclear factor-kappaB (NF-kappaB) signaling [13,15-17]."

sparser
"Following TLR signaling, NF-κB essential modifier (NEMO/IKKγ) undergoes SUMO-2/3 modification, which prevents NEMO binding to the deubiquitinase CYLD and thus indirectly enhancing the IKK activation."

reach
"CYLD interacts with NEMO and is phosphorylated by IKK as a mechanism to inactivate CYLD DUB activity."

No evidence text available

reach
"NEMO is a target for both SUMOylation and ubiquitination, and how NEMO SUMOylation affects the binding of NEMO with deubiquitinase CYLD and thus the activation of the NF-κB pathway is relatively unclear.TLR-dependent NF-κB activation is mediated by the TAK1 signalosome consisting of the TRAF6/TAB2/TAK1 complex."

reach
"Interestingly, CYLD interacts with NEMO and TRAF2, both of which are recruited to the TNF receptor upon ligand binding."

reach
"Mechanistically, CYLD binds to NEMO and TRAF2 and reverses non-K48-linked polyubiquitination of TRAF2, thereby blocking TRAF2 mediated activation of the IKK complex [XREF_BIBR - XREF_BIBR] (XREF_FIG)."

reach
"Indeed, IKKgamma binds CYLD as well as the catalytic subunits of IKK [XREF_BIBR]."

sparser
"Indeed, knockdown of SENP6 impaired the endogenous association of NEMO and CYLD ( xref )."

reach
"Another potential adaptor of CYLD is NEMO, which directly binds CYLD and associates with various IKK regulators, such as RIP1 and TRAF2."

reach
"NEMO is a target for both SUMOylation and ubiquitination, and how NEMO SUMOylation affects the binding of NEMO with deubiquitinase CYLD and thus the activation of the NF-kappaB pathway is relatively unclear."

reach
"NEMO is a target for both SUMOylation and ubiquitination, and how NEMO SUMOylation affects the binding of NEMO with deubiquitinase CYLD and thus the activation of the NF-κB pathway is relatively unclear."

No evidence text available

sparser
"CYLD interacts with NEMO, TNF receptor-associated factor (TRAF)-2, and TRAF-interacting protein and negatively regulates the canonical NF- κ B signal transduction pathway ( Brummelkamp et al. , 2003 [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

sparser
"CYLD interacts with NEMO and is phosphorylated by IKK as a mechanism to inactivate CYLD DUB activity ( xref )."

reach
"As previously mentioned CYLD can bind to NEMO and NF-kappaB that have been identified as its substrates."

reach
"CYLD interacts with NEMO, TNF receptor associated factor (TRAF)-2, and TRAF interacting protein and negatively regulates the canonical NF- kappa B signal transduction pathway (Brummelkamp et al., 2003[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"We show that CYLD binds to the NEMO (also known as IKKgamma) component of the IkappaB kinase (IKK) complex, and appears to regulate its activity through de-ubiquitination of TRAF2, as TRAF2 ubiquitination can be modulated by CYLD."

reach
"Previous studies reported that CYLD binds to IKKgamma and its upstream signaling components including TAK1, TRAF2, TRAF6, and RIP1 [XREF_BIBR - XREF_BIBR]."

No evidence text available

sparser
"NEMO is a target for both SUMOylation and ubiquitination, and how NEMO SUMOylation affects the binding of NEMO with deubiquitinase CYLD and thus the activation of the NF-κB pathway is relatively unclear."

No evidence text available

sparser
"Three independent studies have recently shown that CYLD binds to NEMO and facilitates the disassembly of K63-linked polyubiquitin chains on TRAF2, TRAF6 and NEMO [22 •• –24 •• ] ."

sparser
"Another potential adaptor of CYLD is NEMO, which directly binds CYLD and associates with various IKK regulators, such as RIP1 and TRAF2."

sparser
"Indeed, IKKγ binds CYLD as well as the catalytic subunits of IKK [ xref ]."

No evidence text available

reach
"Recently, it was reported that CYLD directly interacts with NEMO and IKKgamma and TRAF2 in the NF-kappaB signaling pathway."

sparser
"CYLD associates with zinc-finger of NEMO, cleaves non-K48-linked poly-ubiquitin chains attached to NEMO, and negatively modulates TRAF-mediated activation of IKK xref ."

sparser
"Removal of Lys-63-chains from TRAFs requires that CYLD physically (and transiently) interact with NEMO, e.g. in response to TNF-α stimulation."

reach
"Notably, the deubiquitinase CYLD could interact with NEMO and cleave these polyubiquitin chains, thus acting as a negative regulator of NF-kappaB signaling XREF_BIBR."

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

reach
"CYLD physically interacts with and deubiquitinates NEMO, thereby negatively regulating NF-kappaB activation [XREF_BIBR]."

sparser
"However, the SUMOylation effectively impairs the interaction between NEMO and CYLD, suggesting that the SUMO-moiety (∼12 kDa) might directly mask the binding surface."

reach
"In cells, CYLD reportedly interacts with both NEMO and IKKgamma and TRAF (Brummelkamp et al., 2003; Kovalenko et al., 2003; Trompouki et al., 2003); however, it is unlikely that only CYLD links NEMO a[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

sparser
"CYLD binding to NEMO is indeed required for its phosphorylation by the IKK complex, which in turn inhibits its DUB activity, leading to NF-κB activation xref ."

reach
"Strikingly, GST-CYLD (470-684 aa) could pull down neither the NEMO-SUMO-3 nor the SUMOylated NEMO (XREF_FIG, left panel and XREF_FIG), whereas GST-IKKbeta (644-756 aa) could pull down both the NEMO-SUMO-3 and the SUMOylated NEMO (XREF_FIG, right panel and XREF_FIG), indicating that the SUMO-3 modification specifically impaired the interaction between NEMO and CYLD."

reach
"Here we report that CYLD, a tumour suppressor that is mutated in familial cylindromatosis, interacts with NEMO, the regulatory subunit of IKK."